MichaelEzekowitzMD

Cardiology • Bryn Mawr, PA

Cardiac Electrophysiology, Echocardiography, Non-Invasive Cardiology

Physician

Join to view full profile

Dr. Ezekowitz is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Ezekowitz's full profile

Already have an account?

Office
830 Old Lancaster Rd
Ste 301
Bryn Mawr, PA 19010
Phone+1 610-389-7626

Fax+1 610-525-2114

Education & Training

University of Cape Town Faculty of MedicineClass of 1970

Certifications & Licensure

PA State Medical License 2000 - 2026
CT State Medical License 1982 - 2002
MD State Medical License 1977 - 1988
OK State Medical License 1978 - 1988
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Cardiovascular Disease

Awards, Honors, & Recognition

Fellow (FACC) American College of Cardiology

Clinical Trials

Efficacy and Safety Study of an Antiarrhythmic Drug to Treat Atrial Fibrillation in Patients With Pacemakers Start of enrollment: 2006 Jul 01
Completed
Phase 2
Phase 2 Study of the Safety, Tolerability and Pilot Efficacy of Oral Factor Xa Inhibitor Betrixaban Compared to Warfarin Start of enrollment: 2008 Oct 01
Completed
Phase 2

Publications & Presentations

PubMed

Residual Stroke Risk Among Patients With Atrial Fibrillation Prescribed Oral Anticoagulants: A Patient-Level Meta-Analysis From COMBINE AF.
Linda S Johnson, Alexander P Benz, Ashkan Shoamanesh, John W Eikelboom, Michael Ezekowitz
Journal of the American Heart Association. 2024-09-03
2 citations
The ATHERO-AF Study: A Need to Optimize AF Management in an Environment of Medical Advancement.
Michael D Ezekowitz, Ibrahim Alameh, Mohammed Kamareddine
JACC. Advances. 2024-08-01
2 citations
Emergency department visit for atrial fibrillation: sex differences in treatment and outcomes in the Global RE-LY AF Registry.
Linda S Johnson, Yuxuan Jiang, Judy Luu, Isabelle C Van Gelder, Clare Atzema
European Heart Journal. 2024-07-09

Journal Articles

Original Investigation Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial Fibrillation
Michael Ezekowitz, MD, ScienceDirect
Concomitant Oral Anticoagulant and Nonsteroidal Anti-Inflammatory Drug Therapy in Patients with Atrial Fibrillation
Michael Ezekowitz, MD, JACC: Cardiovascular Imaging
Choosing a Particular Oral Anticoagulant and Dose for Stroke Prevention in Individual Patients with Non-Valvular Atrial Fibrillation: Part 1
Jonathan L Halperin, Elaine M Hylek, Michael D Ezekowitz, James Aisenberg, European Heart Journal

Lectures

Highlights in Anti-Coagulation
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
NOACs Post Cardioversion and Atrial Appendage Occlusion/Exclusion
2019 ACC Scientific Session & Expo, New Orleans - 3/18/2019
Engage @ACC.19 Studio: Cardiology Contest
2019 ACC Scientific Session & Expo, New Orleans - 3/16/2019

Press Mentions

ESC: Apixaban Bests Heparin in Cardioversion TreatmentAugust 30th, 2017
Merican Heart Association/American College of Physicians Ask Force on Clinical Competence and TrainingOctober 3rd, 2006

Professional Memberships

American College of Cardiology - ACC
Member